Today: 14 May 2026
Browse Category

Financial Forecasts 6 December 2025 - 7 December 2025

RCAT Stock Forecast for 2025–2026: Can Red Cat Holdings Turn the Drone Supercycle Into Lasting Gains?

RCAT Stock Forecast for 2025–2026: Can Red Cat Holdings Turn the Drone Supercycle Into Lasting Gains?

Red Cat Holdings closed at $8.02 on December 5, 2025, valuing the company at about $957 million, roughly 52% below its October high. Shares jumped nearly 9% after Red Cat named a new CFO and promoted its CFO to COO on December 2. Trading volume was about half the daily average. The stock remains volatile, sitting 75% above its 52-week low but still down 5% year-over-year.
7 December 2025
····
INO Stock: Inovio’s FDA BLA Milestone, New Equity Offerings and 2026 Catalyst – Latest News and Forecasts (December 7, 2025)

INO Stock: Inovio’s FDA BLA Milestone, New Equity Offerings and 2026 Catalyst – Latest News and Forecasts (December 7, 2025)

Inovio Pharmaceuticals closed at $2.07 on December 5, up 2.5% for the day and nearly 20% over the past 10 sessions, with volume near 1 million shares. The stock recently crossed its 200-day moving average, while short interest remains high at 34% of daily volume. Wall Street’s average 12-month price target is $9, despite continued losses and minimal revenue.
7 December 2025
···
KULR Stock in 2025: Q3 Earnings, Bitcoin Treasury Strategy, and Wall Street Forecasts Explained

KULR Stock in 2025: Q3 Earnings, Bitcoin Treasury Strategy, and Wall Street Forecasts Explained

KULR Technology Group shares traded near $3.93 in early December 2025, with a market cap around $180 million and daily volume of 1.36 million. The stock surged 1,819% in 2024 after a $21 million Bitcoin purchase, then fell over 50% in 2025. KULR supplies battery safety and thermal management tech for aerospace and defense, including NASA-certified products.
7 December 2025
····
Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Merck closed an $8 billion senior notes offering, likely to help fund its $9.2 billion Cidara Therapeutics acquisition. The company also reported new regulatory wins and raised its dividend, but faced a patent setback for subcutaneous Keytruda in Germany. Merck shares ended December 5 at $99.72, down 1.2%, and remain near the top of their 52-week range. Trading volume was above average.
7 December 2025
···
Upstart Stock (UPST) in December 2025: Can the AI Lender Turn Explosive Growth Into Sustainable Gains?

Upstart Stock (UPST) in December 2025: Can the AI Lender Turn Explosive Growth Into Sustainable Gains?

Upstart Holdings shares closed near $46.75 on December 7, 2025, valuing the AI lender at over $4 billion amid sharp volatility and short interest above 20%. The stock is down about 35% year-to-date despite a return to GAAP profitability and accelerated revenue growth. Recent technical signals remain mixed, with some trends turning bullish but overall models still rating UPST a “Sell.”
7 December 2025
···
Rivian (RIVN) Stock Forecast for December 2025: Recall Fallout, AI Day Hype and Volkswagen Deal Shape the 2026 Outlook

Rivian (RIVN) Stock Forecast for December 2025: Recall Fallout, AI Day Hype and Volkswagen Deal Shape the 2026 Outlook

Rivian shares closed at $17.95 on December 5, just below a 52-week high, valuing the company at $21.5 billion. The stock is up 30–45% year-over-year despite a recall of nearly 35,000 electric delivery vans and several layoffs. Analysts rate the stock “Hold.” No injuries have been reported from the recall, which does not affect Rivian’s consumer vehicles.
7 December 2025
····
GE Stock in December 2025: Latest News, Analyst Forecasts and Valuation After the Pullback

GE Stock in December 2025: Latest News, Analyst Forecasts and Valuation After the Pullback

GE Aerospace shares closed at $284 on December 6, down 2–3% for the day and about 10% below their October record. The stock is up 77% year-to-date, with a $299 billion market cap and a trailing P/E of 38. GE, now focused on aerospace after spinning off its energy and healthcare units, reported strong Q3 2025 earnings and raised full-year guidance in October.
7 December 2025
··
MGM Resorts International (MGM) Stock Today: Big Buyers, Analyst Downgrades and 2026–2030 Forecasts on December 6, 2025

MGM Resorts International (MGM) Stock Today: Big Buyers, Analyst Downgrades and 2026–2030 Forecasts on December 6, 2025

MGM Resorts shares closed at $36.07 on December 5, up 1.9%, with short interest at 8.8% of float and a market cap near $9.8 billion. Norges Bank disclosed a new $60.6 million stake, raising institutional ownership to about 68%. The stock trades above its 200-day moving average. Technical indicators remain mostly positive despite a recent Wall Street price target cut.
7 December 2025
··
Schwab U.S. Dividend Equity ETF (SCHD): Latest News, Dividend Outlook and Analyst Forecasts – December 6, 2025

Schwab U.S. Dividend Equity ETF (SCHD): Latest News, Dividend Outlook and Analyst Forecasts – December 6, 2025

Schwab U.S. Dividend Equity ETF (SCHD) closed at $27.71 on December 5, 2025, with $71.5 billion in assets and a 0.06% expense ratio. The fund posted a 1-year return of about -3% but maintains a 10-year annualized return near 11.4%. SCHD saw $137 million in net inflows over the past week. Its SEC yield stands around 3.8%, below the 8% yield of rival JEPI.
7 December 2025
··
Eli Lilly (LLY) Stock on 6 December 2025: Zepbound Price Cuts, $1 Trillion Milestone and 2026 Forecasts

Eli Lilly (LLY) Stock on 6 December 2025: Zepbound Price Cuts, $1 Trillion Milestone and 2026 Forecasts

Eli Lilly shares traded near $1,010 on December 6, 2025, with a market value just under $1 trillion after a brief pullback from record highs. The company cut list prices on Zepbound vials this week, pressuring margins and sending the stock lower. Zepbound and Mounjaro generated $10.1 billion in Q3 sales, making Lilly’s GLP-1 drugs the world’s top-selling franchise. Most analysts maintain Buy ratings, with 12-month targets around $1,060–$1,090.
6 December 2025
···
Moderna (MRNA) Stock Jumps on Vaccine Safety Study and $1.5B Lifeline: Latest News and Forecasts as of December 6, 2025

Moderna (MRNA) Stock Jumps on Vaccine Safety Study and $1.5B Lifeline: Latest News and Forecasts as of December 6, 2025

Moderna shares closed at $27.70 on December 5, up 8.7% on volume over 16 million. The rally followed a major French study showing no increase in long-term mortality from mRNA COVID vaccines and a new $1.5 billion credit facility. The stock is still down more than 50% over the past year despite recent gains. Year-to-date performance remains negative at –38.7%.
6 December 2025
··
AppLovin (APP) Stock Soars on AI Adtech Boom: Latest News, SEC Probe, Price Targets and 2025–2030 Forecast

AppLovin (APP) Stock Soars on AI Adtech Boom: Latest News, SEC Probe, Price Targets and 2025–2030 Forecast

AppLovin shares traded near $691.94 on December 6, 2025, close to a record high and up 80% in a year, with a market cap near $231 billion. Q3 revenue jumped 68% to $1.41 billion and net income hit $836 million. Institutional investment surged after S&P 500 inclusion in September. The company faces SEC scrutiny over data practices, insider selling, and a forward P/E in the mid-40s.
6 December 2025
···
Alphabet Stock on Dec. 6, 2025: AI Chips, Antitrust Ruling and 2026 Forecasts

Alphabet Stock on Dec. 6, 2025: AI Chips, Antitrust Ruling and 2026 Forecasts

Alphabet Inc. traded just below record highs on December 6, 2025, with GOOGL opening near $321 and GOOG quoted around $322, valuing the company at about $3.9 trillion. Shares have surged nearly two-thirds in 2025, driven by growth in Gemini AI, Google Cloud, and custom AI chips. A U.S. court let Alphabet keep Chrome and Android but imposed new data-sharing rules. Investors remain cautious amid regulatory pressures and insider sales.
6 December 2025
····
Arm Holdings PLC ADR (ARM) Stock Today: South Korea AI Pact, DreamBig Deal, and 2026 Forecasts – December 6, 2025 Update

Arm Holdings PLC ADR (ARM) Stock Today: South Korea AI Pact, DreamBig Deal, and 2026 Forecasts – December 6, 2025 Update

Arm Holdings (NASDAQ: ARM) closed at about $141–142 on December 5, with a market cap near $150 billion. On December 6, Arm and South Korea announced a partnership to launch a chip-design school and train 1,400 specialists by 2030. SoftBank holds roughly 87% of Arm, and institutional investors own most of the public float. The stock trades at a trailing P/E of about 181.
6 December 2025
····
SoundHound AI (SOUN) Stock: Latest News, Analyst Forecasts and 2026 Outlook – December 6, 2025

SoundHound AI (SOUN) Stock: Latest News, Analyst Forecasts and 2026 Outlook – December 6, 2025

SoundHound AI closed at $12.76 on December 5, 2025, after a year marked by a 42% decline despite strong revenue growth. The company posted Q3 revenue of $42 million, up 68% year over year, and raised full-year guidance. Shares dropped 9.5% after earnings, driven by a GAAP net loss of $109.3 million and acquisition-related charges. SoundHound ended Q3 with $269 million in cash and no debt.
6 December 2025
·
CAVA Group Inc (CAVA) Stock Outlook 2026: Institutional Buying, Q3 Reset and Analyst Price Target Forecasts

CAVA Group Inc (CAVA) Stock Outlook 2026: Institutional Buying, Q3 Reset and Analyst Price Target Forecasts

CAVA shares closed December 5 at just over $53, down more than 60% from their 52-week high of $151. Norges Bank disclosed a $56 million stake, while Baird Financial Group and New York State Common Retirement Fund also sharply increased holdings. About 73% of CAVA’s float is now held by institutions. Insider Kenneth Robert Bertram sold 3,788 shares but retains over 51,000.
6 December 2025
··
Carnival Corp (CCL) Stock: Latest News, Analyst Forecasts and 2026 Outlook as of December 6, 2025

Carnival Corp (CCL) Stock: Latest News, Analyst Forecasts and 2026 Outlook as of December 6, 2025

Carnival shares traded near $25.87 on December 6, with a market cap around $30 billion. The company posted record Q3 2025 net income of $1.9 billion and raised full-year earnings guidance. Despite strong results, the stock is down 18% over the past three months amid concerns over rising costs and heavy debt. Volatility remains high, with a beta above 2.5.
6 December 2025
···
Reddit (RDDT) Stock Outlook on December 6, 2025: Can the Rally Run After a 450% Post‑IPO Surge?

Reddit (RDDT) Stock Outlook on December 6, 2025: Can the Rally Run After a 450% Post‑IPO Surge?

Reddit Inc. shares closed at $234.11 on Dec. 5, up 5.1%, after rebounding sharply from a post-September slump. The company reported Q3 net income of $163 million on $585 million in revenue, with daily active users rising 19% to 116 million. Reddit’s stock has surged over 450% since its March 2024 IPO. Market cap stands near $44 billion.
6 December 2025
···
Duke Energy (DUK) Stock on December 6, 2025: Price, Nuclear Push, Rate Hike Fight and 2026 Wall Street Forecasts

Duke Energy (DUK) Stock on December 6, 2025: Price, Nuclear Push, Rate Hike Fight and 2026 Wall Street Forecasts

Duke Energy shares closed at $116.52 on December 5, down for a fifth straight session and about 10% below their October high. Trading volume spiked to 4 million shares. First Trust Advisors sharply cut its stake, while other institutions added positions. On December 4, the U.S. Solicitor General urged the Supreme Court to reject Duke’s antitrust appeal in a case brought by NTE Energy.
6 December 2025
···
AGNC Investment Corp (AGNC) Stock Hits New 52‑Week High as Yield Tops 13% – Latest News, Dividend Update and 2026 Forecast

AGNC Investment Corp (AGNC) Stock Hits New 52‑Week High as Yield Tops 13% – Latest News, Dividend Update and 2026 Forecast

AGNC Investment Corp. closed at $10.62 on Friday, hitting a new 52-week high and yielding about 13.6% on a $1.44 annual dividend. The mortgage REIT’s market cap stands near $11 billion. AGNC invests mainly in agency-backed mortgage securities and finances its portfolio through leverage. Its Q3 2025 results showed mixed performance.
6 December 2025
···
1 … 27 28 29 30 31 … 42

Stock Market Today

  • LunR Royalties (TSXV:LUNR) Soars 84.6% in 2024 Despite No Revenue, Valuation Questions Arise
    May 14, 2026, 1:18 AM EDT. LunR Royalties (TSXV:LUNR) surged 84.6% year to date, reaching a CA$24 share price and a market cap near CA$1.68 billion. Despite this rally, the company posted no revenue and a net loss of CA$0.96 million. Its price-to-book ratio stands at an extreme 430.4x, vastly exceeding the Canadian metals and mining sector average of 3.2x. This valuation implies high investor expectations for future royalty income and project success, though the lack of current earnings and large valuation gap raise concerns about potential downside if exploration or timelines falter. Investors are urged to weigh these risks carefully before committing, considering the company's momentum balanced against its unproven profitability.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 14.05.2026

14 May 2026
LIVEMarkets rolling coverageStarted: May 14, 2026, 12:00 AM EDTUpdated: May 14, 2026, 1:30 AM EDT LunR Royalties (TSXV:LUNR) Soars 84.6% in 2024 Despite No Revenue, Valuation Questions Arise May 14, 2026, 1:18 AM EDT. LunR Royalties (TSXV:LUNR) surged 84.6% year to date, reaching a CA$24 share price and a market cap near CA$1.68 billion. Despite this rally, the company posted no revenue and a net loss of CA$0.96 million. Its price-to-book ratio stands at an extreme 430.4x, vastly exceeding the Canadian metals and mining sector average of 3.2x. This valuation implies high investor expectations for future royalty income and project
Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

14 May 2026
Enovix shares dropped 12.9% to $6.35 after hours Wednesday despite beating first-quarter revenue and adjusted-loss estimates. The decline followed news that smartphone battery qualification remains unfinished, with the company passing 72 of 75 customer tests. Revenue rose 49% to $7.6 million. Enovix cited progress in defense, industrial, and smart-eyewear sales.
Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

14 May 2026
Lightwave Logic reported Q1 revenue up 27% to $29,000 and a net loss widening to $6.3 million. Shares rose 14% after the company said it is negotiating a supply and licensing deal for high-volume production in 2027. Four Fortune 500 customers are now in Stage 3 prototyping. Cash and equivalents totaled about $100 million as of May 11.
Go toTop